Through this project, Amin and DRCMR colleagues aim to investigate how inhibitory control and electrophysiological (EEG) signals in Parkinson’s disease are dynamically affected by dopaminergic replacement therapy.

This research is being conducted at DRCMR, where their goal is to improve both motor and non-motor symptoms in Parkinson’s disease by better understanding the cortico-basal ganglia circuit.

Congratulations, Amin.